Traders Buy Valeant Pharmaceuticals International Inc. (VRX) on Weakness


Investors bought shares of Valeant Pharmaceuticals International Inc. on weakness during trading hours on Thursday. $522.09 million flowed into the stock on the tick-up and $498.90 million flowed out of the stock on the tick-down, for a money net flow of $23.19 million into the stock.



from Biotech News